Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
ACIP vote ends use of combined MMRV for children under 4; Connecticut clinicians warn of coverage and operational impacts
Summary
At the advisory committee meeting Commissioner Manisha Juthani reviewed ACIP's recent vote to stop recommending the combined MMRV vaccine for children under 4, noted Connecticut data on usage, and discussed coverage consequences for Medicaid, CHIP and Vaccines for Children program beneficiaries.
The Connecticut Department of Public Health advisory committee discussed a recent ACIP decision to remove the combined measles-mumps-rubella-varicella (MMRV) vaccine as a recommended option for children younger than 4, and the consequences that decision carries for insurer coverage and pediatric operations.
Commissioner Manisha Juthani summarized ACIP's vote and Connecticut data: "The main change that we're seeing right now is that because MMRV is no longer recommended for children under the age of 4, it will not be a choice for practitioners or for families." She reported that about 17 percent of Connecticut parents had chosen MMRV for the first dose at 12'15 months, while 84 percent received MMRV at the 4'6 year second dose in state data that mirror national trends.
Why it matters: Because ACIP recommendations determine insurer obligations, several…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
